Trials / Completed
CompletedNCT03419143
Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants
Abatacept - Long-Term Real-Life Experience in Psoriatic Arthritis (PsA) in Germany: an Observational Study (ALTEA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 190 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is a long-term, observational study of Abatacept in patients with Psoriatic Arthritis, a chronic inflammatory disorder.
Conditions
Timeline
- Start date
- 2018-03-02
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
- First posted
- 2018-02-01
- Last updated
- 2022-05-31
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03419143. Inclusion in this directory is not an endorsement.